The best known human α-helical cathelicidin LL-37 has a lower cytotoxic activity toward both tumor and normal cells (IC50 of >10 μM and HC50 of ∼60 μM) (Oren et al., 1999). The gene discussed is CAMP; the disease is neoplasm.